Live feed
Filing
SC 13G/A
SC 13G/A0000902219-19-000469·Ra Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Ra Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 74933V108
Event date: 2019-10-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 179,804
- Percent of class
- 0.3800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-19-000469
- Form type
- SC 13G/A
- Filer
- Ra Pharmaceuticals, Inc.
- CIK
- CIK 1481512
- Filed
- Nov 08, 2019
- Reporting period
- Oct 31, 2019
- Description
- Schedule 13G beneficial ownership